What type of face mask should we choose in coronavirus disease 2019 pandemic considering photoprotective effectiveness?

Photodermatol Photoimmunol Photomed. 2022 Nov;38(6):548-554. doi: 10.1111/phpp.12788. Epub 2022 Apr 10.

Abstract

Background: Wearing a face mask is one of the most effective personal protective strategies to diminish the spread of coronavirus disease 2019 (COVID-19). Several dermatological outcomes were reported because of the prolonged use of face masks, especially due to the constant mask-on policy, but the photoprotective effect of face masks has received less attention.

Objective: The aim of this study was to provide guidance in the use of face masks by comparing the photoprotective effects of routinely used masks.

Methods: A total of 12 frequently used face masks were tested, including certified respirators, Korea filter (KF)94, KF-anti-droplet (KF-AD), and KF80. The amount of light that penetrates each face mask was measured using a light sensor that can quantify Ultraviolet A (UVA), visible light (VL), and infrared A (IR-A) rays.

Results: Black-colored KF94 masks and surgical masks reduced penetration of UVA, VL, and IR-A by approximately 100%. The UVA penetration decreased on average by 95.51%, 90.97%, 85.06%, and 86.41% with white-colored KF94, KF-AD, KF80, and surgical masks, respectively. The VL and IR-A were blocked by approximately 75.58%, 66.16%, 59.18%, and 64.48% with white-colored KF94, KF-AD, KF80, and surgical masks, respectively.

Conclusion: In conclusion, the different photoprotective effectiveness of face masks was mainly determined by colors, and therefore, black-colored, multi-layered respirators can be recommended in terms of photoprotection in the COVID-19 pandemic. The quantified comparative results will be helpful to the person with pre-existing photo-aggravated dermatosis, especially in the season of the high intensity of sunlight.

Keywords: COVID-19; face mask; photoprotection.

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Masks
  • Pandemics* / prevention & control
  • Republic of Korea
  • SARS-CoV-2